@article{article, title  = {{Ceralasertib plus Durvalumab in Ras Mutant and Ras Wild-Type Advanced Non–Small Cell Lung Cancer: Two Cohorts of the Phase II Platform National Lung Matrix Trial}},

 publisher = {{American Association for Cancer Research (AACR)}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/246766 https://doi.org/10.1158/1078-0432.ccr-26-1365 }},

 year = {{2026}},

 month = {{10}},

 author = {{Middleton G and Buchanan R and Savage J and De La Mata Chicharro J and Mehmi M and Wilkins RJ and Kelly RDW and Wilson C and Kanhere A and Robbins HL and Ames L et al}},

 doi = {{10.1158/1078-0432.ccr-26-1365}},

 journal = {{Clinical Cancer Research}},

 pages = {{OF1-OF14}},

 note = {{Accessed on 2026/11/05}}}